Net loss of Valiant Laboratories reported to Rs 7.06 crore in the quarter ended December 2025 as against net profit of Rs 2.35 crore during the previous quarter ended December 2024. Sales rose 48.91% to Rs 52.46 crore in the quarter ended December 2025 as against Rs 35.23 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales52.4635.23 49 OPM %-1.701.76 - PBDT-0.942.14 PL PBT-2.991.62 PL NP-7.062.35 PL Powered by Capital Market - Live News

Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News

Net profit of Valiant Laboratories reported to Rs 0.20 crore in the quarter ended September 2025 as against net loss of Rs 4.74 crore during the previous quarter ended September 2024. Sales rose 115.08% to Rs 46.20 crore in the quarter ended September 2025 as against Rs 21.48 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales46.2021.48 115 OPM %0.15-31.38 - PBDT0.81-3.39 LP PBT0.28-3.91 LP NP0.20-4.74 LP Powered by Capital Market - Live News

Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live News

Valiant Laboratories announced that the Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live News